Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05442346 |
|
Recruitment Status :
Suspended
(Sponsor decision)
First Posted : July 5, 2022
Last Update Posted : February 28, 2024
|
Sponsor:
Bioray Laboratories
Collaborator:
First Affiliated Hospital of Guangxi Medical University
Information provided by (Responsible Party):
Bioray Laboratories
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Suspended |
|---|---|
| Estimated Primary Completion Date : | September 8, 2024 |
| Estimated Study Completion Date : | November 30, 2024 |